Aptose Biosciences Inc. (APS) Fundamentals

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Luxeptinib, its panFMS-like tyrosine kinase 3 / pan-Bruton's tyrosine kinase inhibitor, is enrolling patients in a Phase 1, multicenter, open label, dose-escalation study with expansions to assess the safety, tolerability, PK, and preliminary efficacy of CG-806 in patients with chronic lymphocytic leukemia (CLL/SLL) or non-Hodgkin lymphomas (NHL). HM43239 is an oral potent myeloid kinome inhibitor, targeting a constellation of kinases operative in myeloid malignancies.
SHARE INFORMATION
Market Cap$ 71,989,893
Shares Outstanding92,257,227
Float91,044,246
Percent Float98.65%
Short Interest1,055,580.00
Short Percent Float100.0%
Short Interest Ratio37.95
Short Interest Date2022-09-15
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.92
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions77
Institutional Holdings Date2022-09-30
Institutional Bought Previous 3 Months753,045
Institutional Holdings Percent27.4%
Institutional Sold Previous 3 Months4,264,282
Insider Holdings Date2022-09-30
Insider Bought Previous 3 Months670,000
Insider Holdings Percent1.4
Insider Sold Previous 3 Months-
Insider Shares Owned27,285,715
TRADING INFO
52 Week High$ 3.53
52 Week Low$ 0.75
52 Week High Change$ -72.14
21 Day Moving Average$ 0.873333
21 Day Extended Moving Average$ 0.862774
50 Day Moving Average$ 0.9714
50 Day Extended Moving Average$ 0.956156
200 Day Moving Average$ 1.3245
200 Day Extended Moving Average$ 1.5714
10 Day Average Volume7,902
20 Day Average Volume15,029
30 Day Average Volume13,110
50 Day Average Volume13,230
Alpha0.00423
Beta1.465509
Standard Deviation0.231044
R20.075465
7 Day Price Change$ 0.02
7 Day Percent Change2.63%
21 Day Price Change$ -0.20
21 Day Percent Change-20.41%
30 Day Price Change$ -0.25
30 Day Percent Change-24.27%
Month to Date Price Change$ -0.04
Month to Date Percent Change-4.88%
Quarter to Date Price Change$ -0.04
Quarter to Date Percent Change-4.88%
180 Day Price Change$ -1.03
180 Day Percent Change-56.91%
200 Day Price Change$ -0.77
200 Day Percent Change-49.68%
Year to Date Price Change$ -0.95
Year to Date Percent Change-54.91%

Aptose Biosciences Inc. (APS) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.01
Total Debt To Equity0.01
Int Coverage0.00
Current Ratio6.90
Leverage Ratio1.20
Quick Ratio6.70
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-1.00
Enterprise Value$ -13,511,264
Price to Sales0.00
Price to Free Cash-1.70
PE High Last 5 Years-2.10
Price To Book0.93
Price To Cash Flow0.00
PE Low Last 5 Years-7.40
Price to Tangible Book1.01
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-69.08
Return on Equity-76.93
Return on Capital-74.73

Aptose Biosciences Inc. (APS) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEOWilliam G. Rice
Emplyoees41
Last AuditUQ
CIK0000882361
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address251 Consumers Road
Suite 1105
Toronto, ON M2J 4R3
Websitehttps://www.aptose.com
Facsimile-
Telephone+1 650 718-5028
Emailir@aptose.com
Your Recent History
TSX
APS
Aptose Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20221005 13:06:18